Clinical Trial Update: FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating first-line FOLFIRI plus cetuximab for metastatic colorectal cancer, including regular dermal prophylaxis to prevent acneiform fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cetuximab (cetuximab)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: Dr. Carl Schimanski | Conditions: Colorectal Cancer Metastatic | Phase 4 | Status: UNKNOWN